Goat Serum (Aimspro) research Recently, there has been some information in the News regarding Goat Serum being used to create a drug called Aimspro as a potential treatment for multiple sclerosis. This treatment reportedly uses antibodies from the serum (the fluid portion of blood) of goats that have been inoculated with a variety of vaccines, to generate neutralising antibodies. Antibodies are proteins produced by white blood cells in response to an antigen (foreign protein), to destroy/neutralize the antigen. The anti-inflammatory component of the serum is thought by researchers to be ‘potentially useful’ in the treatment of MS. Aimspro is manufactured by Daval International Ltd (East Sussex, UK). According to the National MS Society, this firm was cited for misleading advertising about Aimspro on its Web site in July 2004 by the UK Medicines and Healthcare Products Regulatory Agency, and the company responded by removing most of its claims for the product. At this point, stories are that the goat serum is reported to work for 85% of patients who use it, even to the point of reversing some damage, and possibly delaying progression of MS. While the idea of this drug sounds intriguing, there has to date been no published evidence to back up the claims, and until such is seen, it is difficult to come to any conclusion. Also, the is some concern about people bying "goat serum" rip-offs over the Internet. The following message was posted on the This Is MS website: Daval is the manufacturer behind the Aimspro ("goat serum") treatment currently in trials for MS. The problem is that you can find labs selling "Goat Serum" online-- but this is NOT the same product being used in the trials. In fact, the goat serum being sold over the Internet can be deadly if injected! Please read the comments from Daval below: "[Daval has] recently been approached by an individual seeking dosage advice for a “Goat Serum” purchased on the internet. This “Goat Serum”, is not similar in any manner to that of the product used by Daval for the treatment of Multiple Sclerosis. It appears to be a research grade product which if injected would very likely cause death by anaphylactic shock. “Aimspro”, which is made from the serum derived from a goat and whose immune system has been challenged in a very specific proprietary manner, has a very complex molecular structure which has been modified in order to make it acceptable for human use. Daval does not sell any of its products on the Internet." This treatment uses antibodies from the serum (the fluid portion of blood) of goats that have been inoculated with a variety of vaccines, to generate neutralising antibodies. Antibodies are proteins produced by white blood cells in response to an antigen (foreign protein), to destroy/neutralise the antigen. The strong anti-inflammatory component of the serum is thought by researchers to be 'potentially useful' in the treatment of MS. Evidence Much anecdotal evidence seems to exist in support of a beneficial effect in MS but there is no research evidence or published information available to back up the anecdotal claims. Side effects appear to be extremely limited although controlled research is necessary before conclusions can be reached. A large number of people with MS have been receiving goat serum, via informed consent. This means they are receiving it through a GP but are NOT part of a controlled trial. No more people can receive this drug via informed consent. Clinical trials A controlled trial involving 80 participants all with Secondary Progressive MS(where half of the participants receive the treatment and half are on placebo (a dummy treatment) was taking place at St George's Hospital in South London. This trial was halted early in 2005. We await further information on this trial. A second controlled trial occuring in Oxford, involving participants with optic neuritis has been taking place. Neurologists stated recently that further evidence is needed after disappointing trial results. A third trial is being planned, with a focus on acute relapses in MS. This trial is awaiting ethical approval - once received, information regarding recruitment to this trial will be posted on this website. Availability Speaking in Parliament in December 2004, Health Minister Lord Warner said: "The treatment Aimspro is not licensed for use in the UK and, therefore, will not be widely available in the NHS. A specialist neurologist who wished to prescribe the treatment on a named-patient basis would need to agree funding with the appropriate primary care organisation and make a special arrangement with the manufacturer." As with any therapy or potential therapy, the MS Society recommends people with MS should consult their neurologist before embarking on treatment. Neurologists can be expected to be cautious about prescribing the drug until peer-reviewed evidence from trials of the drug's effectiveness and safety is published.

The stuff from that study is not available to the public. It is much better to go to google and put in these words; Edgar Cayce Multiple Sclerosis then read all you can. This has been studied a great deal, and those who kept up the treatments had great results. Sometimes it can take three years to recover enough to be rid of a wheelchair. It stems from a lack of gold in the nerves to throw off toxins, and also adhesions in the lacteal ducts, as well as mis-alignment of the spine. These lead to bad eliminations of toxins. Sometimes colonics were even recomended. Bad assimilation of foods is attibuted to this. Boiling vegitables a long time helps with assimilation. Not like you would always eat that, but eliminate fats, and sugars from the diet is recomended as well. There is a message recomendation, and some type of battery thing alternated from one ankle and oposite wrist to the other daily as well. Only consistancy has results, and the contacts must be cleaned maticulously each time they are used. You must read the Cayce way to make the battery though. Good luck, and remember this has a lot to do with attitude as well. Keep taking the meds the doc gives. Take care.